This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new study from an industry advocacy group in California examines the content of dozens of unregulated intoxicating “hemp” products that are easily available in the Golden State despite being banned by statelaw. However, the following year the DEA put off its decision pending further public commentary.
The Institute for Justice argues that the seizures violated statelaw, federal law, and the U.S. It includes cops who use federal civil forfeiture laws to steal money earned by state-legal marijuana businesses. Constitution. Reports Reason. Here’s the introduction to the must-read Reason story.
On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.
Fighting Investment Fraud in the Marijuana Business Industry. with defrauding investors about returns in cannabis businesses after Greenview used misleading marketing materials to raise over $3 million from investors. This is not the first SEC effort against investor fraud in the marijuana business industry.
There are questions about the logistics of opening and running one of these types of businesses, given the complex interplay of laws and regulations promulgated by bodies from the U.S. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.
Although 18 states have fully legalized, cannabis is still a sticky issue for banks and other financial institutions because it remains illegal at the federal level. The cannabis industry might look like just another business for local police, where legal, but the DEA and other federal agencies have a different outlook.
For starters, this case clarifies that the federal government can neither force the states to enforce federal marijuana policy, nor can they prohibit the states from implementing or revising their own marijuana policies. Murphy holds that state-law repeals are not pre-emptible.
In fact, a well-funded and coordinated effort is underway to not only take those products away from you but also to dismantle the rights weve fought hard to secure under statelaws and limited federal protections. These conversations are playing out in marketplaces, among advocates and cannabis business owners, but not in Washington.
Kelly O’Connor, director of business development at Oregon-based Columbia Laboratories, said her company has seen a 30% increase in requests for delta-8 product testing compared to this time last year. D-8 is legal federally, and most statelaws don’t specifically address it. States already closing loopholes.
The legal cannabis business is spreading like weeds. As several states and foreign countries have enacted laws decriminalizing or legalizing marijuana for medicinal or recreational use, a fresh rush of reefer madness has overtaken the business world. practicing law in the U.S. practicing law in the U.S.
The STATES Act passes in Congress, the President signs it and it becomes law which means that in the states where cannabis is legal : Banking system becomes available to cannabis businesses. 280E is effectively repealed and cannabis businesses are no longer subject to the broad disallowance of expenses.
Limitless does business as Cali Kulture. What about statelaws banning delta-8? The Ninth Circuit’s ruling does not change statelaws that prohibit or otherwise regulate delta-8. The preemption language in the 2018 Farm Bill does not extend to state controlled substance laws. What about the DEA?
Though ABA specified that it was not taking a position on marijuana legalization generally, it recognized that conflicting federal and state cannabis policies are untenable and have created complications for cannabis businesses operating in compliance with statelaw.
In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. Below is a list of statelaw updates to look forward to this year. 1, out-of-state medical marijuana patients may access Arkansas’ program to purchase cannabis for up to 90 days. Happy 2022!
For the purpose of the CSA, the Attorney General delegates its power to the DEA and the HHS delegates its power to the Food and Drug Administration (FDA). Of the two Cabinet members, Becerra has the better cannabis credentials, having served as the Attorney General for the state of California. Where Does Joe Biden Stand? criticized ?the
The legal cannabis business is spreading like weeds. As several states and foreign countries have enacted laws decriminalizing or legalizing marijuana for medicinal or recreational use, a fresh rush of reefer madness has overtaken the business world. Yes, also be worried if you engage in business in the U.S.
Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. You can find a summary here and the full draft language here. We absolutely share Sen. Marijuana Times. An End to Cannabis Banking Woes?
Cannabis-related permits and lab certifications Permits are a critical part of any cannabis business, but there are some that are unique to cannabis testing labs. First, since cannabis legalization is a state-level phenomenon, any cannabis lab needs a state license.
PUBLISHER: CANNABIS LAW REPORT. The website Weedmaps bills itself as “a community where businesses and consumers can search and discover cannabis products, become educated on all things cannabis, review cannabis businesses and connect with other like-minded users,” but is more succinctly described as Yelp for pot. John McKay.
Congress : “ Cannabis has gone from the butt of jokes on Capitol Hill to milestone hearings and the introduction of landmark legalization reform packages that offer the potential to pave the way for billions of dollars in new business opportunities nationwide.
After attending the International Cannabis Business Conference (ICBC) in Berlin at the end of April, I was reminded, yet again, of how draconian U.S. marijuana laws truly are. As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. In contrast, the U.S. How the U.S.
And then you scroll a little further down and discover that the new Farm Bill is going to legalize hemp farming in the United States for the first time in eighty years ( huzzah!). billion dollars in the weed business ( f**k!). All because federal law still sees him as a wonton criminal. Or that Big Tobacco just invested $2.4
State legal cannabis businesses are used to the specter of the federal government in the rear view mirrors of their lives and businesses. In the January subpoena (which is standard and boilerplate), the DEA wrote that “the information sought. is relevant and material to a legitimate law enforcement inquiry.”
Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.
The answer is that they are basically “legal” in the same sense that cannabis businesses are legal: they violate federal law but can comply with statelaw if licensed. Following said case, the DEA created a procedure for petitioning for religious exemptions to the Controlled Substances Act. Let’s break it down.
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. . View original article. The post NationalLink Inc.
Here are some prominent examples: Wall Street Journal: Marijuana Businesses Seek to Make Federal Restrictions Go Up in Smoke Marijuana Business Daily: Marijuana companies suing US attorney general in federal prohibition challenge Reuters: Cannabis companies in Massachusetts challenge constitutionality of federal drug law Here’s the deal.
It’s been a busy week for the Golden State. Assembly Bill 1525 allows cannabis banking under California statelaw. In other news, a federal court ruled that the state must turn over information concerning three marijuana businesses to the DEA. Further bulletins as events warrant. california.
First and foremost, rescheduling does not mean that state-legal cannabis markets will be federally compliant. In other words, all California cannabis businesses will still violate federal law. Rescheduling also won’t impact statelaw where it counts. So for now, California’s still on its own.
The inevitability of enforcement actions, civil penalties, loss of licensure, and even potentially criminal liability (depending on the nature of the violation) mean that cannabis businesses must get in the mindset of compliance. The point is that compliance is key and non-compliant businesses may eventually learn that the hard way.
Here are the other main business and regulatory highlights as we see them: Role of the FDA and USDA. There are a couple of exceptions to this list, probably the most important one being that the offenses won’t qualify if a state is examining the issue and still willing to give a state license regardless of the offense.
Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). Decriminalization of Cannabis, Recognition of Statelaw Controlling Cannabis. It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF.
Back in August 2020, the Drug Enforcement Administration (the “DEA”) released its Interim Final Rule (the “ IFR” ) in which the agency stated, in part, that “[a]ll synthetically derived tetrahydrocannabinols remain schedule I controlled substances.” Re-published with the permission of Harris Bricken and The Canna Law Blog.
Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). Option 2 would likely be hugely expensive: we would see increased business failure as well as market consolidation.
Despite legalization in the majority of states, however, federal law (i.e., the Controlled Substances Act of 1970) does not allow any trade or business in trafficking either medical or recreational marijuana. This conflict between federal and statelaw has raised concerns among CPAs providing services to the marijuana industry.
Solicited by a formal Congressional Request for Information (RFI) on ideas for how to regulate hemp-derived CBD, public feedback included a diverse range of perspectives from businesses, trade associations, and other stakeholders. Moreover, several states have been stymied by the conflicting messages from the federal government.
There are questions about the logistics of opening and running one of these types of businesses, given the complex interplay of laws and regulations promulgated by bodies from the U.S. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.
If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision. On May 21, 2024, the DEA opened a 62-day public comment period, which concluded on July 22, 2024. Currently, rescheduling marijuana to Schedule III of the CSA is being considered.
In turn, here are the top 6 questions we’ve been getting lately around ketamine clinics: Isn’t the regulation of ketamine clinics just like adult-use/medicinal cannabis businesses? In fact, the two are treated wildly differently by federal and state governments. This answer depends on statelaw. No, it’s not.
Federal law enforcement would no longer be able to bust people for weed-related crimes, unless they were in violation of statelaw. Legal weed businesses would be able to open bank accounts, access loans, or list on the US stock market. Anyone wishing to comment can send an email to [email protected] by September 1.
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
The act would transfer agency functions with regard to cannabis from the Drug Enforcement Administration’s (DEA) jurisdiction to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), the Department of Health and Human Services (HHS) and the Department of the Treasury. .
As of this writing, cannabis remains a prohibited Schedule 1 drug, defined by the DEA as having “no currently accepted medical use and a high potential for abuse.” . Most Americans have access to either medical or adult-use cannabis under statelaws. Since 2012, 18 states and Washington, D.C.,
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content